Institution
Shaoxing Second Hospital
Recent research
- Health & MedicineOpen access
BACKGROUND: This study assessed the real-world effectiveness and safety of a fixed-dose combination (FDC) of metformin and empagliflozin in Chinese patients with type 2 diabetes mellitus (T2DM). METHODS: This prospective, multicenter, real-world study enrolled consecutive patient...
- AI & ComputingOpen access
This article explores the clinical value of the artificial intelligence computer-aided diagnosis system in the diagnosis of superficial lymph nodes. In this study, characteristic ultrasonic parameters of 185 cases of lymph nodes (including 110 benign and 75 malignant) confirmed b...
- Health & MedicineOpen access
Androgen receptor pathway inhibitors (ARPIs) are widely used across multiple prostate cancer disease states, but fracture outcomes are inconsistently reported across randomized trials. We aimed to quantify the risks of all-grade and grade ≥ 3 trial-reported fracture-related adver...
- Health & MedicineOpen access
Routine inflammatory and cardiac biomarkers may help risk-stratify patients receiving immune checkpoint inhibitors (ICIs). The ECG monitoring endpoint and oncologic survival outcomes are distinct. We examined whether baseline cardiac biomarkers were associated with adjudicated ne...
- Health & MedicineOpen access
To systematically evaluate the risk of neutropenia associated with androgen receptor pathway inhibitor (ARPI) intensification in patients with prostate cancer across phase 3 randomized controlled trials. This systematic review and meta-analysis was conducted in accordance with PR...
- Health & MedicineOpen access
To develop and evaluate a multimodal Vision-Mamba deep learning (DL) model integrating clinical data, noncontrast computed tomography (NCCT) hematoma features, and shell features to predict early hematoma expansion (EHE) in hypertensive intracerebral hemorrhage (HICH). In this mu...